Comparison of myeloablative and nonmyeloablative hematopoietic stem cell transplantation for treatment of chronic myeloid leukemia
- 1 June 2007
- journal article
- Published by Springer Science and Business Media LLC in International Journal of Hematology
- Vol. 86 (3), 275-281
- https://doi.org/10.1007/bf03006933
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)–based mutagenesis screen: high efficacy of drug combinationsBlood, 2006
- Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation–related imatinib failureBlood, 2006
- In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain MutantsCancer Research, 2005
- Loss of Response to Imatinib: Mechanisms and ManagementHematology, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2003
- Current Therapy of Chronic Myelogenous Leukemia.Internal Medicine, 2002
- The Biology of Chronic Myeloid LeukemiaThe New England Journal of Medicine, 1999
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsThe New England Journal of Medicine, 1979
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973
- The minute chromosome (Ph1) in chronic granulocytic leukemiaBlut: Zeitschrift für die Gesamte Blutforschung, 1962